BUZZ-Contract research organizations gain after Trump win

Reuters11-06

** Shares of contract research organizations up 1% to 3% premarket after Donald Trump is elected U.S. president for a second term

** Thermo Fisher Scientific up 2%, Danaher up 1.9%, Icon up 1.6% and Waters up 2.8%

** "Any potential changes to the Inflation Reduction Act dynamics would likely slow the recent trend of portfolio pruning, which would be positive for the reboot in biopharma demand" - Leerink analysts on implications of Trump reelection

** Contract research organizations, which make tools and services used in drug development, witnessed reduced spending from biotech clients last year

** Charles River Laboratories' shares rise 12.4% to $212.00 premarket as the company raises its annual profit forecast on stabilizing biotech demand

** Up to last close, TMO up 5.7%, DHR up 8.1%, ICLR down 20%, WAT up 17.6% and CRL down 20.2% YTD

(Reporting by Christy Santhosh)

((Christy.Santhosh@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment